Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
EKSO 
Ekso Bionics Holdings Inc (EKSO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: EKSO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $37.5
1 Year Target Price $37.5
| 1 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -33.11% | Avg. Invested days 19 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 7.93M USD | Price to earnings Ratio - | 1Y Target Price 37.5 |
Price to earnings Ratio - | 1Y Target Price 37.5 | ||
Volume (30-day avg) 2 | Beta 0.89 | 52 Weeks Range 2.73 - 22.95 | Updated Date 06/29/2025 |
52 Weeks Range 2.73 - 22.95 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -7.2 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -61.51% | Operating Margin (TTM) -96.59% |
Management Effectiveness
Return on Assets (TTM) -23.25% | Return on Equity (TTM) -80.71% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 5538664 | Price to Sales(TTM) 0.45 |
Enterprise Value 5538664 | Price to Sales(TTM) 0.45 | ||
Enterprise Value to Revenue 0.32 | Enterprise Value to EBITDA 0.46 | Shares Outstanding 2366670 | Shares Floating 1659226 |
Shares Outstanding 2366670 | Shares Floating 1659226 | ||
Percent Insiders 5.5 | Percent Institutions 10.73 |
Analyst Ratings
Rating 2 | Target Price 37.5 | Buy 1 | Strong Buy 1 |
Buy 1 | Strong Buy 1 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Ekso Bionics Holdings Inc
Company Overview
History and Background
Ekso Bionics Holdings Inc. was founded in 2005. It focuses on developing and manufacturing wearable exoskeletons to enhance human strength, endurance, and mobility. Initially focused on military applications, it has since expanded to medical and industrial fields.
Core Business Areas
- Medical: Develops and markets exoskeletons for rehabilitation and mobility assistance for individuals with spinal cord injuries, stroke, and other neurological conditions.
- Industrial: Offers exoskeletons for industrial workers to reduce strain and fatigue, increasing productivity and safety in physically demanding jobs.
Leadership and Structure
The leadership team typically includes a CEO, CFO, CTO, and other executives overseeing various departments such as sales, marketing, engineering, and operations. The organizational structure is hierarchical, with departments reporting to executive leadership.
Top Products and Market Share
Key Offerings
- EksoNR: An exoskeleton designed for neurorehabilitation, primarily used in hospitals and rehab centers. Market share in rehabilitation exoskeletons is estimated around 15-20%. Competitors include ReWalk Robotics (RWLK) and Hocoma (private).
- EksoVest: A lightweight, upper-body exoskeleton for industrial workers. Market share data is less readily available, but Ekso Bionics is a significant player in this segment. Competitors include SuitX (private) and Ottobock (private).
Market Dynamics
Industry Overview
The exoskeleton market is growing, driven by increasing demand for rehabilitation solutions, improved workplace safety, and advancements in robotics and sensor technology. It's segmented into medical, industrial, and military applications.
Positioning
Ekso Bionics is positioned as a leader in both the medical and industrial exoskeleton markets, with a focus on innovation and technological advancements. Their competitive advantage lies in their established brand, diverse product portfolio, and strong relationships with healthcare providers and industrial partners.
Total Addressable Market (TAM)
The global exoskeleton market is projected to reach billions of USD by 2030. Ekso Bionics is strategically positioned to capture a significant portion of this TAM by focusing on its core strengths in medical and industrial applications.
Upturn SWOT Analysis
Strengths
- Established brand recognition
- Diverse product portfolio
- Strong technology and innovation capabilities
- Strategic partnerships
- First mover advantage in some segments
Weaknesses
- High product costs
- Limited market adoption due to regulatory hurdles
- Dependence on reimbursement policies in the medical sector
- Competition from larger, more established companies
- Relatively small revenue base
Opportunities
- Expanding into new geographic markets
- Developing new exoskeleton applications
- Increasing adoption of exoskeletons in industrial settings
- Securing favorable reimbursement policies
- Partnering with other technology companies
Threats
- Intense competition
- Technological obsolescence
- Economic downturns
- Changes in government regulations
- Product liability risks
Competitors and Market Share
Key Competitors
- RWLK
- ITRI
- HAL
Competitive Landscape
Ekso Bionics competes on technology, features, and market presence. Some competitors are larger and have greater financial resources.
Growth Trajectory and Initiatives
Historical Growth: Growth has been uneven, with periods of rapid expansion followed by consolidation. Requires detailed financial data for specific growth rates.
Future Projections: Analyst projections vary. Consult financial news sources for up-to-date estimates of revenue growth and profitability.
Recent Initiatives: Includes new product launches, partnerships, and expansion into new markets.
Summary
Ekso Bionics is a pioneering exoskeleton company with strong technology and market positions in rehabilitation and industrial applications. Its high product costs and reliance on favorable reimbursement policies remain challenges. Successful execution of strategic initiatives and market expansion are crucial for sustained growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- SEC filings (10-K, 10-Q)
- Financial news websites (e.g., Yahoo Finance, Bloomberg)
- Industry reports
Disclaimers:
This analysis is for informational purposes only and does not constitute investment advice. Financial data is subject to change. Market share data is approximate and based on available estimates.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Ekso Bionics Holdings Inc
Exchange NASDAQ | Headquaters San Rafael, CA, United States | ||
IPO Launch date 2014-01-16 | CEO & Director Mr. Scott G. Davis | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 61 | Website https://www.eksobionics.com |
Full time employees 61 | Website https://www.eksobionics.com | ||
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EVO, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. It also offers EksoCare offering an extended warranty and premium service options, repairs and maintenance services, and training programs. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.